GILD - Company ID 0000882095
The table below shows GILEAD SCIENCES, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | $5.41B | $5.34B | $6.00B |
| Short-term investments | $68.00M | $0.00 | $1.18B | $973.00M | $1.18B | $1.41B |
| Receivables | $4.91B | $4.42B | $4.66B | $4.78B | $4.49B | $4.89B |
| Inventory | $1.77B | $1.71B | $1.79B | $1.51B | $1.62B | $1.68B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $18.34B |
| $19.17B |
| $16.09B |
| $14.44B |
| $14.77B |
| $16.00B |
| Property, plant & equipment | $5.61B | $5.41B | $5.32B | $5.47B | $5.12B | $4.97B |
| Goodwill | $8.31B | $8.31B | $8.31B | $8.31B | $8.33B | $8.11B |
| Total assets | $59.02B | $58.99B | $62.13B | $63.17B | $67.95B | $68.41B |
| Accounts payable | $715.00M | $833.00M | $550.00M | $905.00M | $705.00M | $844.00M |
| Total current liabilities | $11.81B | $12.00B | $11.28B | $11.24B | $11.61B | $11.40B |
| Long-term debt | $22.13B | $24.90B | $23.19B | $22.96B | $25.18B | $28.64B |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | $13.73B | $11.50B | $16.30B | $15.69B | $16.32B | $14.38B |
| Total equity | $22.70B | $19.33B | $22.83B | $21.24B | $21.07B | $18.20B |